Differential regulation of two uridine diphospho- glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells

Endocrinology

Volumn 138, Issue 7, 1997, Pages 2998-3005

  Guillemette, Chantal ^a   Lévesque, Eric ^a   Beaulieu, Martin ^a   Turgeon, David ^a   Hum, Dean W ^a   Bélanger, Alain ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; EPIDERMAL GROWTH FACTOR; GLUCURONOSYLTRANSFERASE; MESSENGER RNA;

ARTICLE; ENZYME REGULATION; GLUCURONIDATION; GROWTH REGULATION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

EID: 0030991972     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.7.5226     Document Type: Article

References (60)

1. Wilding G 1992 The importance of steroid hormones in prostate cancer. Cancer Surv 14:113-130
2. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:C113-C118
3. Labrie C, Bélanger A, Labrie F 1988 Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123:1412-1417
4. Andersson S, Bishop RW, Russell DW 1989 Expression, cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J Biol Chem 264:16249-16255
5. Lorence MC, Murry BA, Trant JM, Mason JI 1990 Human 3β-hydroxysteroid dehydrogenase/Δ5-Δ4isomerase from placenta, expression in nonsteroidogenic cells of a protein that catalyzes the dehydrogenation/isomerization of C21 and C19 steroids. Endocrinology 126:2493-2498
6. Labrie F, Simard J, Luu-the V, Bélanger A, Pelletier G 1992 Structure and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J Steroid Biochem Mol Biol 43:805-826
7. Tephly T, Green M, Puig J, Irshaid Y 1988 Endogenous substrates for UDP-glucuronosyltransferases. Xenobiotica 18:1201-1210
8. Clarke DJ, Burchell B 1994 The uridine diphosphate glucuronosyltransferase multigene family: function and regulation. In: Coffman FC (ed) The Uridine Diphosphate Glucuronosyltransferase Multigene Family, pp 3-43
9. Bélanger A, Brochu M, Cliche J 1986 Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. J Clin Endocrinol Metab 62:812-815
10. Bélanger A, Couture J, Caron S, Roy R 1990 Determination of nonconjugated and conjugated steroid levels in plasma and prostate after separation on C-18 columns. In: Castagnetta L, d'Aquino S, Labrie F, Bradlow HL (eds) Steroid Formation, Degradation and Action in Peripheral, Normal and Neoplastic Tissues. Ann NY Acad Sci 595:251-258
11. Bélanger G, Beaulieu M, Marcotte B, Lévesque E, Guillemette C, Hum DW, Bélanger A 1995 Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line. Mol Cell Endocrinol 113:165-173
12. Chen F, Ritter JK, Wang MG, Mcbride OW, Lubet RA, Owens IS 1993 Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms. Biochemistry 32:10648-10657
13. Beaulieu M, Lévesque E, Hum DW, Bélanger A 1996 Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 271:22855-22862
14. Green M, Eyitayo MO, Tephly RT 1994 Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Disp 22:799-805
15. Habib FK, Chisholm GD 1991 The role of growth factors in the human prostate. Scand J Urol Nephrol [Suppl] 138:53-58
16. Steiner MS 1993 Role of peptide growth factors in the prostate: a review. Urology 42:99-110
17. Savarese DMF, Savarese TM, Valinski H, Quesenberry PJ 1995 Expression of cytokines colony-stimulating factors and their receptors in human prostatic carcinoma cell lines. Proceedings of the American Association tor Cancer Research 36:642 (Abstract)
18. Schuurmans ALG, Bolt J, Mulder E 1988 Androgens and transforming growth factor α modulate the growth response to epidermal growth factor in human prostatic tumor cells. Mol Cell Endocrinol 60:101-104
19. Wilding G, Valverius E, Knabbe C, Gelmann EP 1989 Role of transforming growth factor α in human prostate cell growth. Prostate 15:1-12
20. Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J, Lee C, Kozlowski JM 1991 Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor α. Cancer Res 51:2780-2785
21. Knabbe C, Kellner U, Schmahl M, Voight KD 1991 Growth factors in human prostate cancer cells: implications for an improved treatment of prostate cancer. J Steroid Biochem Mol Biol 40:1-3
22. Wilding G 1991 Response of prostate cancer cells to peptide growth factors: transforming growth factor β. Cancer Surv 11:147-163
23. MacDonald A, Habib FK 1992 Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer 65:177-182
24. Reed MJ, Coldham NG, Patel SR, Ghilchick MW, James VHT 1992 Interleukin-1 and interleukin-6 in breast cyst fluid: Their role in regulating aromatase activity in breast cancer cells. J Endocrinol 132:R5-R8
25. Wahe M, Antonipillai I, Horton R 1993 Effects of transforming growth factor beta and epidermal growth factor on steroid 5α-reductase activity in genital skin fibroblasts. Mol Cell Endocrinol 98:55-59
26. Horton R, Pasupuletti V, Antonipillai I 1993 Androgen induction of steroid 5α-reductase may be mediated via insulin-like growth factor-I. Endocrinology 133:447-451
27. Feinberg BB, Anderson DJ, Steller MA, Fulop V, Berkowitz RS, Hill JA 1994 Cytokine regulation of trophoblast steroidogenesis. J Clin Endocrinol Metab 78:586-591
28. Lebrethon MC, Jaillard C, Naville D, Begeot M, Saez JM 1994 Regulation of corticotropin and steroidogenic enzyme mRNAs in human fetal adrenal cells by corticotropin, angiotensin-11 and transforming growth factor β1. Mol Cell Endocrinol 106:137-143
29. Reed MJ, Purohit A, Duncan LJ, Singh A, Roberts CJ, Williams GJ, Potter BVL 1995 The role of cytokines and sulpharase inhibitors in regulating oestrogen synthesis in breast tumours. J Steroid Biochem Mol Biol 53:413-420
30. Guillemette C, Bélanger A 1995 Glucuronosyltransferase activity in human cancer cell line LNCaP. Mol Cell Endocrinol 107:131-139
31. Guillemette C, Hum DW, Bélanger A 1996 Evidence for a role of glucuronosyltranferase in the regulation of androgen action in the human prostatic cancer cell line LNCaP. J Steroid Biochem Mol Biol 57:225-231
32. Guillemette C, Hum DW, Bélanger A 1996 Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line. Endocrinology 137:2872-2879
33. Feinberg AP, Vogelstein B 1983 A technique for radiolabeling DNA restricton endlonuclease fragments to high specific activity. Anal Biochem 132:6-13
34. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 227:680-685
35. Goldman D, Yawetz A 1990 The interference of arochlor 1254 with progesterone metabolism in guinea pig adrenal and testes microsomes. J Biochem Toxicol 5:99-107
36. Schuurmans AL, Bolt J, Veldscholte J, Mulder E 1991 Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 40:193-197
37. Lyall RM, Zilberstein A, Gazit A, Gilon C, Levitzki A, Schlessinger J 1989 Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J Biol Chem 264:14503-14509
38. Gill G, Kawamoto T, Cochet C, Le AD, Sato GH, Masui H, McLeod C, Mendelsohn J 1984 Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem 259:7755-7760
39. Huggins C, Hodges CV 1941 Studies of prostatic cancer. I. Effect of castration, estrogen and androgen injections on serum phosphatases in metastasic carcinoma of the prostate. Cancer Res 1:293-297
40. Labrie F, Dupont A, Bélanger A 1985 Complete androgen blockade for the treatment of prostate cancer. In: Devita VT, Mellman S, Rosenberg SA (eds) Important Advances in Oncology, pp 193-217
41. Wilding G 1995 Endocrine control of prostate cancer. Cancer Survey 23:43-62
42. Labrie F, Simard J, Luu-The V, Bélanger A, Pelletier G 1992 Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J Steroid Biochem Mol Biol 43:805-826
43. Couet J, Simard J, Martel C, Trudel C, Labrie Y, Labrie F 1992 Regulation of 3-ketosteroid reductase messenger ribonucleic acid levels and 3β-hydroxysteroid dehydrogenase/Δ5-Δ4isomerase activity in rat liver by sex steroids and pituitary hormones. Endocrinology 131:3034-3044
44. Ware JL 1993 Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev 12:287-301
45. Connolly JM, Rose DP 1990 Production of epidermal growth factor and transforming growth factor a by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16:209-218
46. Carruba G, Leake RE, Rinaldi F, Chalmers D, Comito L, Sorci C, Pavone Macaluso M, Castagnetta LA 1994 Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells. Steroids 59:412-420
47. Cleave M, Hsieh JT, Gao CA, von Eschenbach AC, Chung LW 1991 Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res 51:3753-3761
48. Nakamoto T, Chang CS, Li AK, Chodak GW 1992 Basic fibroblast growth factor in human prostate cancer cells. Cancer Res 52:571-577
49. Zuck B, Goepfert C, Nedlin Chittka A, Sohrt K, Voigt KD, Knabbe C 1992 Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaP. J Steroid Biochem Mol Biol 41:659-663
50. Henttu P, Liao SS, Vihko P 1992 Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (messenger KNA), but down-regulate the prostatic acid phosphatase messenger RNA in the LNCaP cell line. Endocrinology 130:766-772
51. Montgomery BT, Young CY, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, Tindall DJ 1992 Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic aclenocarcinoma cell line, LNCaP. Prostate 21:63-73
52. Henttu P, Vihko P 1993 Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res 53:1051-1058
53. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H 1994 Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478
54. Veldscholte J, Berrevoets CA, Mulder E 1994 Studies on the human prostatic cancer cell line LNCaP. J Steroid Biochem Mol Biol 49:341-346
55. Haque SJ, Petersen DD, Nebert DW, Mackenzie PI 1991 Isolation, sequence, and developmental expression of rat UGT2B2: the gene encoding a constitutive UDP glucuronosyltransferase that metabolizes etiocholanolone and androsterone. DNA Cell Biol 10:515-524
56. Mackenzie PI 1990 The cDNA sequence and expression of a variant 17β-hydroxysteroid UDP-glucuronosyltransferase. J Biol Chem 265:8699-8703
57. Adler AJ, Danielsen M, Robins DM 1992 Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proc Natl Acad Sci 89:11660-11663
58. Schule R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM 1990 Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226
59. Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, Herrlich P 1990 Antitumor promotion and antiinflammation: down modulation of AP-1 (fos/jun) activity by glucocorticoid hormone. Cell 62:1189-1204
60. Beato M, Herrlich P, Schütz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857